Michael Dunne, PhD

Associations

• Immunology
• BioEngineering

Education & Training

Graduate:

• University of Toronto, PhD - Pharmaceutical Sciences

Fellowship:

• Harvard University - BioEngineering

Dr. Dunne’s primary research focus is on the development of biomaterials-based approaches to control immune cell phenotype for the purpose of improving the efficacy and biodistribution of immune cell therapies. He is further interested in improving anti-cancer cell therapies though the development of novel nano- and micro-scale drug delivery formulations as well as the use of externally applied stimuli (e.g. radiotherapy and/or hyperthermia) in order to alter cell therapy accumulation and distribution within the tumor.